This work in canine spontaneous forms of human neuropathies allowed the identification of a novel gene GDNF and its regulation mechanism, not yet described in human HSAN, opening the field of clinical trials to benefit both canine and human medicine. This evidence concerns the gene GDNF and hereditary sensory and autonomic neuropathy.